Plain-English translation of NCT07018713 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing ®, a medication given by injection into muscles in the head and neck, to see if it can help prevent chronic migraines. The study will compare the medication to a placebo (a dummy injection with no active ingredient) to measure whether it reduces the number of migraine days people experience each month. About 780 people with chronic migraines will participate.
Chronic migraine is a debilitating condition that affects many people's quality of life. Researchers want to find out whether this medication can help reduce how often migraines occur, giving patients relief and better control over their symptoms.
You likely qualify if…
You likely don't qualify if…
You will be in the trial for about 52 to 55 weeks. You'll visit the clinic in person 6 times (including an initial screening visit, 4 treatment visits where you receive injections, and a final visit), and have 8 additional visits by phone or video call. The treatment involves injections into muscles around the head and neck, repeated about every 12 weeks for a total of 4 treatment sessions. You'll also keep a headache diary to track your migraine days throughout the trial.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
United States